echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Colum Pharmaceuticals: Medium/long-chain fat emulsions are evaluated by generic consistency

    Colum Pharmaceuticals: Medium/long-chain fat emulsions are evaluated by generic consistency

    • Last Update: 2021-01-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 18, Colum Pharmaceuticals announced that the company recently obtained the approval of the State Drug Administration issued the chemical "medium/long-chain fat emulsion" of the "Drug SupplementAl Application Approval Notice", the drug through generic quality and efficacy consistency evaluation, to provide energy and essential fatty acids for patients in need of intravenous nutrition.
    intestinal nutrition plays an important role in the treatment of patients with critical injury and severe trauma, which can quickly provide the nutrients needed by the body, promote the recovery of patients and improve the prognostics of the disease.
    At present, our company has been approved to market 8 new intestinal nutrition products, covering single bags, two-room bags, three cavity bags in different packaging forms, and because of differentiated product formulations clinically can meet different types (liver function impairment, peri-surgical period, critical illness, etc.) and different energy needs of patients nutritional treatment.
    medium/long chain fat emulsion is the most widely used fatty milk in clinical practice, with rapid energy supply, high efficiency nitrogen saving, liver protection and other advantages, has been widely recommended by domestic and foreign guidelines for liver function damage and tumor and other patients.
    /long-chain fat emulsion (C8-24Ve) is the 2020 edition of the National Health Insurance Directory, with sales of 780 million yuan in China in 2019.
    this time our company's first domestic through the consistent evaluation, will further enhance the market competitiveness of the species.
    addition, with the product through the first domestic consistent evaluation, and the follow-up series of varieties continued to be approved, our company will become a complete category, the domestic leading out-of-intestinal nutrition system solutions suppliers.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.